£111.33

This is the most expensive it has ever been. Walk away.

£111 today · previous high £111 · all-time low £108

Humana Innovations for Next-Generation Antibody-Drug Conjugates (Cancer Drug Discovery and Development)

Amazon

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 61 days · 61 data points (no recent data)

Historical
Generating forecast…
£111.33 £107.65 £108.45 £109.25 £110.06 £110.86 £111.66 25 July 2026 09 August 2026 24 August 2026 08 September 2026 23 September 2026
View at Amazon ↗

Price data last checked 30 day(s) ago - will refresh soon

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↑ Price chart
when this has been cheap or pricey
↑ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price Distribution

Price distribution over 61 days • 2 price levels

Days at Price
Current Price
60 days 1 day · current 0 15 30 45 60 £108 £111 Days at Price

Price Analysis

Most common price: £108 (60 days, 98.4%)

Price range: £108 - £111

Price levels: 2 different prices over 61 days

Description

Antibody-drug conjugates (ADCs) stand at the verge of a transformation. Scores of clinical programs have yielded only a few regulatory approvals, but a wave of technological innovation now empowers us to overcome past technical challenges. This volume focuses on the next generation of ADCs and the innovations that will enable them. The book inspires the future by integrating the field’s history with novel strategies and cutting-edge technologies. While the book primarily addresses ADCs for solid tumors, the last chapter explores the emerging interest in using ADCs to treat other diseases. The therapeutic rationale of ADCs is strong: to direct small molecules to the desired site of action (and away from normal tissues) by conjugation to antibodies or other targeting moieties. However, the combination of small and large molecules imposes deep complexity to lead optimization, pharmacokinetics, toxicology, analytics and manufacturing. The field has made significant advances in all of these areas by improving target selection, ADC design, manufacturing methods and clinical strategies. These innovations will inspire and educate scientists who are designing next-generation ADCs with the potential to transform the lives of patients.

Product Specifications

Brand
Humana
Format
hardcover
Domain
Amazon UK
Release Date
11 June 2018
Listed Since
15 February 2018

Barcode

No barcode data available

Similar Products You Might Like

Antibody-Drug Conjugates: 1045 (Methods in Molecular Biology, 1045)
98% match

Antibody-Drug Conjugates: 1045 (Methods in Molecular Biology, 1045)

Humana

£80.67 19 Sep 2026
Antibody-Drug Conjugates: Methods and Protocols: 2078 (Methods in Molecular Biology, 2078)
97% match

Antibody-Drug Conjugates: Methods and Protocols: 2078 (Methods in Molecular Biology, 2078)

Humana

£80.67 23 Sep 2026
Cytotoxic Payloads for Antibody–Drug Conjugates: Volume 71 (Drug Discovery Series)
97% match

Cytotoxic Payloads for Antibody–Drug Conjugates: Volume 71 (Drug Discovery Series)

Royal Society of Chemistry

£132.53 24 Aug 2026
Wiley A Beginner's Guide to Targeted Cancer Treatments
96% match

Wiley A Beginner's Guide to Targeted Cancer Treatments

Wiley

£44.89 26 Sep 2026
Immuno-Oncology: Cellular and Translational Approaches (Methods in Pharmacology and Toxicology)
96% match

Immuno-Oncology: Cellular and Translational Approaches (Methods in Pharmacology and Toxicology)

Humana

£84.27 18 Sep 2026
Tumor Immunology: Methods and Protocols: 1393 (Methods in Molecular Biology, 1393)
96% match

Tumor Immunology: Methods and Protocols: 1393 (Methods in Molecular Biology, 1393)

Humana

£69.37 22 Sep 2026
Immunotherapy of Cancer: Innovative Treatment Comes of Age
96% match

Immunotherapy of Cancer: Innovative Treatment Comes of Age

Springer

£106.33 02 Oct 2026
Macromolecular Anticancer Therapeutics (Cancer Drug Discovery and Development)
95% match

Macromolecular Anticancer Therapeutics (Cancer Drug Discovery and Development)

Humana

£148.21 24 Sep 2026
Current Immunotherapeutic Strategies in Cancer: 214 (Recent Results in Cancer Research, 214)
95% match

Current Immunotherapeutic Strategies in Cancer: 214 (Recent Results in Cancer Research, 214)

Springer

£87.93 01 Oct 2026
Diagnostic and Therapeutic Antibodies: 40 (Methods in Molecular Medicine, 40)
95% match

Diagnostic and Therapeutic Antibodies: 40 (Methods in Molecular Medicine, 40)

Humana

£59.83 23 Sep 2026
Critical Developments in Cancer Immunotherapy
95% match

Critical Developments in Cancer Immunotherapy

£421.00 01 Oct 2026
Novel Immunotherapeutic Approaches to Cancer Treatment - Springer
95% match

Novel Immunotherapeutic Approaches to Cancer Treatment - Springer

Springer

£108.91 03 Oct 2026
Tumor Antigens Recognized by T Cells and Antibodies: 3 (Tumour Immunology and Immunotherapy Series)
95% match

Tumor Antigens Recognized by T Cells and Antibodies: 3 (Tumour Immunology and Immunotherapy Series)

CRC Press

£170.01 23 Sep 2026
Novel Immunotherapeutic Approaches to Cancer Treatment - Springer
95% match

Novel Immunotherapeutic Approaches to Cancer Treatment - Springer

Springer

£114.88 02 Oct 2026
Multifunctional Nanocarriers (Micro and Nano Technologies)
95% match

Multifunctional Nanocarriers (Micro and Nano Technologies)

Elsevier

£146.49 25 Aug 2026
Biomarkers for Immunotherapy of Cancer: Methods and Protocols: 2055 (Methods in Molecular Biology, 2055)
95% match

Biomarkers for Immunotherapy of Cancer: Methods and Protocols: 2055 (Methods in Molecular Biology, 2055)

Humana

£110.83 22 Sep 2026
Principles of Cancer Biotherapy
95% match

Principles of Cancer Biotherapy

Springer

£80.65 22 Aug 2026
Immunotherapy in Translational Cancer Research (Translational Oncology)
95% match

Immunotherapy in Translational Cancer Research (Translational Oncology)

Wiley

£130.00 22 Aug 2026
Cancer Therapy: Monoclonal Antibodies, Lymphokines New Developments in Surgical Oncology and Chemo- and Hormonal Therapy
95% match

Cancer Therapy: Monoclonal Antibodies, Lymphokines New Developments in Surgical Oncology and Chemo- and Hormonal Therapy

Springer

£78.85 13 Sep 2026
Wiley Anticancer Therapeutics - Oncology Drug Design Book
95% match

Wiley Anticancer Therapeutics - Oncology Drug Design Book

Wiley

£138.97 02 Oct 2026
Recombinant Antibodies for Immunotherapy
95% match

Recombinant Antibodies for Immunotherapy

Cambridge University Press

£82.44 03 Oct 2026
Cancer Immunoprevention: Methods and Protocols: 2435 (Methods in Molecular Biology, 2435)
95% match

Cancer Immunoprevention: Methods and Protocols: 2435 (Methods in Molecular Biology, 2435)

Humana

£109.99 17 Sep 2026
Chemical Linkers in Antibody–Drug Conjugates (ADCs): Volume 81 (Drug Discovery Series)
95% match

Chemical Linkers in Antibody–Drug Conjugates (ADCs): Volume 81 (Drug Discovery Series)

Royal Society of Chemistry

£123.84 25 Aug 2026
Nanomedicine in Cancer Immunotherapy (Woodhead Publishing Series in Biomaterials)
95% match

Nanomedicine in Cancer Immunotherapy (Woodhead Publishing Series in Biomaterials)

Elsevier

£165.25 19 Sep 2026